One of the top issues facing the average American today is the prices of drugs (i.e. medications). Drug manufacturers have made money hand over fist at the expense of the American taxpayer. And this is accomplished without little regulation from Congress. With the change of the House this year, we are finally seeing difficult questions being asked of drug manufacturers at Congressional hearings.
In the video below, Congresswoman Alexandria Ocasio-Cortez drills Gilead Science CEO on excessive prices on drugs in America in comparison to the same drug price overseas:
Nice. Finally, someone is willing to press the CEO's of America's major pharmaceutical companies about drug pricing in different countries.
Here is the video of the full Congressional Hearing:
The drug manufacturers have very little interest in lowering their bottom line (profits) to their shareholders. Which is why such Congressional hearings are so important to tease out the real problems with our nations exceedingly high cost of medications. How to solve the issue is beyond the scope of this blog post. Although, bringing the public's attention toward a hearing where questions are being entertained is one step closer toward arriving at a solution.
A solution which is bipartisan and results in a better and healthier United States of America. Drug prices surely do not need to be so exorbitant that a resident of the U.S. cannot afford to get treatment. Especially, when the government provides different forms of subsidies and tax breaks to such large corporations. The time to take action is now.
Related Blog Posts:
New Drug Design Strategies - Consider the Patient during the Design Process
Former FDA Director Asked Congress For Clarity Regarding CBD in Food Products
Food is not addictive, but is filled with Addictive Drugs -- Engineered Chemicals to Elicit Addiction
"Just Make A Generic (Cheaper Version) Of The Drug"? Not So Easy...
Update: On FDA's Policy Agenda For Combatting Opioid Crisis
The future: Making Medicines in your kitchen?
No comments:
Post a Comment